Actemra 162 MG/0.9 ML syringe 0.9ML
Ended Awarded
- Contract number
- SPE2DB25FNVCY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,363
Award facts
- Contract value 100% obligated
- $7,362.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $7,362.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 162 mg/0.9 mL Actemra syringes on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfilled this delivery order under its substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
Actemra is a tocilizumab-based immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, representing the type of specialty pharmaceutical product commonly supplied through DLA's medical supply chain to support military healthcare programs. This delivery order exemplifies AmerisourceBergen's role as a primary pharmaceutical vendor providing a comprehensive range of brand-name medications, generic drugs, and medical supplies to the Defense Health Agency and other federal healthcare systems. The award reflects the contractor's demonstrated capability to meet federal procurement requirements through competitive bidding and its established position as a key supplier for military medical logistics operations worldwide.
Quick answers
Who was awarded contract SPE2DB25FNVCY?
SPE2DB25FNVCY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FNVCY worth?
The government has obligated $7,363 on SPE2DB25FNVCY.
Is contract SPE2DB25FNVCY an order under another contract?
Yes. SPE2DB25FNVCY is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNVCY competed?
The extent of competition for SPE2DB25FNVCY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award